BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2022

Mar 18, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2022-03-15

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-15	Common Stock	A	40280	—	Acquired	378849	Direct
2022-03-15	Common Stock	F	38306	$78.27	Disposed	340543	Direct
2022-03-16	Common Stock	F	5560	$80.72	Disposed	334983	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-15	Stock Option (Right to buy Common Stock)	$78.27	A	58040	Acquired	2032-03-14	Common Stock (58040)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	247533	Indirect

Footnotes

F1: Restricted stock units granted on March 15, 2022. Price not applicable.

F2: Option grant vests 12/36th on March 15, 2023 and 1/36th on the 15th day of each month thereafter.